Major Health Issues in Nova Scotia: An Environmental Scan
Major Health Issues in Nova Scotia: An Environmental Scan
Major Health Issues in Nova Scotia: An Environmental Scan
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
# Reference Brief Notes<br />
families. J.Child <strong>Health</strong> Care; 2004; 8(2):124-<br />
33.<br />
<strong>in</strong> partnership with the family of a child with a long-term illness. The<br />
better nurses know the family and the context <strong>in</strong> which it lives, the<br />
more <strong>in</strong>dividual advice and cop<strong>in</strong>g strategies that they are able to f<strong>in</strong>d<br />
<strong>in</strong> partnership with a family, and thus to support the family <strong>in</strong><br />
achiev<strong>in</strong>g a good quality of life. The theory describes the life of a<br />
family of a child with asthma as a life path. The dimensions of the<br />
family's life-path are environment, the child's becom<strong>in</strong>g ill, the<br />
family's view of health, their attitude towards illness, everyday<br />
rout<strong>in</strong>es and social network. The unpredictability of asthma,<br />
optimism about the future and normalization of life are factors that<br />
guide families towards achievement of a good quality of life for their<br />
17. Kimura,J, DaSilva,K and Marshall,R.<br />
Population management, systems-based<br />
practice, and planned chronic illness care:<br />
Integrat<strong>in</strong>g disease management<br />
competencies <strong>in</strong>to primary care to improve<br />
composite diabetes quality measures.<br />
Dis.Manag.; 2008; 11(1):13-22.<br />
18. Kre<strong>in</strong>dler,SA. Lift<strong>in</strong>g the burden of chronic<br />
disease: What has worked? what hasn't?<br />
what's next? <strong>Health</strong>c.Q.; 12(2):30.<br />
19. Kristofco,RE and Lorenzi,NM. How quality<br />
improvement <strong>in</strong>terventions can address<br />
disparities <strong>in</strong> depression. J.Cont<strong>in</strong>.Educ.<strong>Health</strong><br />
Prof.; 2007; 27 Suppl 1:S33-9.<br />
20. Lameire,N, Stevens,P, Raptis,S, et al.<br />
Individualized risk management <strong>in</strong> diabetics:<br />
How to implement best practice guidel<strong>in</strong>es--<br />
design and concept of the IRIDIEM studies.<br />
Kidney Blood Press.Res.; 2004; 27(3):127-33.<br />
child.<br />
The <strong>in</strong>creas<strong>in</strong>g prevalence of chronic illnesses <strong>in</strong> the United States<br />
requires a fundamental redesign of the primary care delivery system's<br />
structure and processes <strong>in</strong> order to meet the chang<strong>in</strong>g needs and<br />
expectations of patients. Population management, systems-based<br />
practice, and planned chronic illness care are 3 potential processes<br />
that can be <strong>in</strong>tegrated <strong>in</strong>to primary care and are compatible with the<br />
Chronic Care Model. This study illustrates how 1 delivery system<br />
<strong>in</strong>tegrated these disease management functions <strong>in</strong>to the front l<strong>in</strong>es of<br />
primary care and the positive impact of those changes on overall<br />
diabetes quality of care.<br />
There is emerg<strong>in</strong>g consensus that the grow<strong>in</strong>g problem of chronic<br />
disease demands major health system changes, as envisioned <strong>in</strong> the<br />
Chronic Care Model (orig<strong>in</strong>al and expanded). Yet implementation<br />
research has documented the pitfalls of try<strong>in</strong>g to implement the<br />
whole model at once; it is more effective to focus on one highly<br />
important change at a time. This article responds to decision-makers'<br />
need to set priorities by compar<strong>in</strong>g the strength of evidence for<br />
different <strong>in</strong>terventions. It synthesizes a broad range of literature,<br />
<strong>in</strong>clud<strong>in</strong>g numerous systematic reviews and meta-analyses, <strong>in</strong>to<br />
practical guidance on optimal system design for chronic disease<br />
management and prevention.<br />
The quality of depression care, especially care received by m<strong>in</strong>orities,<br />
needs improvement. Several <strong>in</strong>terventions have been developed for<br />
the purpose of improv<strong>in</strong>g the quality of depression management <strong>in</strong><br />
primary care, <strong>in</strong>clud<strong>in</strong>g quality improvement strategies employ<strong>in</strong>g<br />
disease management approaches, the chronic care model, and the<br />
Breakthrough Collaborative Series developed by the Institute for<br />
<strong>Health</strong>care Improvement. This article reviews these <strong>in</strong>terventions and<br />
exam<strong>in</strong>es their potential to contribute to the improvement of<br />
depression care.<br />
The prevalence of type 2 diabetes mellitus is ris<strong>in</strong>g rapidly <strong>in</strong> all<br />
developed countries, particularly <strong>in</strong> the grow<strong>in</strong>g population of<br />
persons >50 years of age. As a dangerous consequence, this is<br />
accompanied by a proportionate <strong>in</strong>crease <strong>in</strong> the <strong>in</strong>cidence of chronic<br />
renal disease. Best practice guidel<strong>in</strong>es support early <strong>in</strong>tervention and<br />
aggressive treatment of hypertension, hyperglycaemia, prote<strong>in</strong>uria,<br />
hypercholesterolemia, and anaemia. To date, guidel<strong>in</strong>e-based<br />
management has been proven to be difficult. This article describes<br />
the concept of the IRIDIEM studies. The objective of these studies is<br />
to endorse and facilitate the use of current best practice guidel<strong>in</strong>es for<br />
the management of frequent comorbid diseases and established risk<br />
factors <strong>in</strong> the treatment of type 2 diabetes associated with chronic<br />
kidney disease. Additionally, IRIDIEM will assess the impact of this<br />
improved disease management model on the progression of chronic